Davis Blaine Insider Trades

Insider Trading History

Track insider trading activity for Davis Blaine. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cartesian Therapeutics
Cartesian Therapeutics RNAC
Chief Financial Officer
Holding Value $759k 121,220 shares
Last Trade
Jan 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$72.2k 10,591 shares
$6.82
$6.26
Cartesian Therapeutics
Cartesian Therapeutics RNAC
Chief Financial Officer
Holding Value $826k 131,811 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$987k 146,000 shares
$6.76
$6.26
Cartesian Therapeutics
Cartesian Therapeutics RNAC
Chief Financial Officer
Holding Value $594k 94,811 shares
Last Trade
Jan 06, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$67.8k 4,028 shares
$16.83
$6.26
Cartesian Therapeutics
Cartesian Therapeutics RNAC
Chief Financial Officer
Holding Value $619k 98,839 shares
Last Trade
Jan 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$66.2k 3,961 shares
$16.72
$6.26
Cartesian Therapeutics
Cartesian Therapeutics RNAC
Chief Financial Officer
Holding Value $644k 102,800 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.09M 64,600 shares
$16.93
$6.26
Selecta Biosciences
Selecta Biosciences SELB
Chief Financial Officer
Holding Value $2.74M 3,110,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.74M 3,110,000 shares
$0.88
$0.88
Cartesian Therapeutics
Cartesian Therapeutics RNAC
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 13, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.1M 1,250,000 shares
$0.88
$6.26
Selecta Biosciences
Selecta Biosciences SELB
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 13, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.1M 1,250,000 shares
$0.88
$0.88
Selecta Biosciences
Selecta Biosciences SELB
Chief Financial Officer
Holding Value $1.1M 1,250,000 shares
Last Trade
Nov 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.59M 1,250,000 shares
$1.27
$0.88
Protara Therapeutics
Protara Therapeutics TARA
Chief Financial Officer
Holding Value $87.2k 20,662 shares
Last Trade
Jul 15, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.9k 5,081 shares
$3.13
$4.22
Protara Therapeutics
Protara Therapeutics TARA
Chief Financial Officer
Holding Value $358k 84,800 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$682k 98,900 shares
$6.90
$4.22
Protara Therapeutics
Protara Therapeutics TARA
Chief Financial Officer
Holding Value $317k 75,000 shares
Last Trade
Jan 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.49M 75,000 shares
$19.82
$4.22
Protara Therapeutics
Protara Therapeutics TARA
Chief Financial Officer
Holding Value $6.25k 1,481 shares
Last Trade
Sep 22, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25k 1,481 shares
$16.91
$4.22
Protara Therapeutics
Protara Therapeutics TARA
Chief Financial Officer
Holding Value $397k 94,000 shares
Last Trade
Feb 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.51M 94,000 shares
$37.30
$4.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up